HEMANT SURGICAL INDUSTRIES LTD IPO
HEMANT SURGICAL INDUSTRIES LTD was a SME IPO, offered at ₹85–₹90 per share. The issue was subscribed 139.7× overall (QIBs 41.05×, NIIs 203.26×, retail 158.73×). It listed on 5 Jun 2023 and closed its first day at ₹171, a listing gain of +90.0% versus the ₹90 issue price.
Frequently asked questions
- How many times was the HEMANT SURGICAL INDUSTRIES LTD IPO subscribed?
- The HEMANT SURGICAL INDUSTRIES LTD IPO was subscribed 139.7× overall — 41.05× in the QIB category, 203.26× among non-institutional investors, 158.73× in retail.
- What were the HEMANT SURGICAL INDUSTRIES LTD IPO listing gains?
- HEMANT SURGICAL INDUSTRIES LTD listed on 5 Jun 2023, closing its first day at ₹171 — a listing gain of +90.0% versus the ₹90 issue price.
- What were the retail allotment odds for the HEMANT SURGICAL INDUSTRIES LTD IPO?
- Retail was subscribed 158.73×, so a single-lot application had roughly a 0.6% chance of allotment (about 1 in 159), and allotment was finalised on 30 May 2023.
- What was the price band and lot size of the HEMANT SURGICAL INDUSTRIES LTD IPO?
- The price band was ₹85–₹90 per share.